|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||17.20 / 28.45|
Stocks move higher as tech sector names make gains.
Futures move higher as tech sector makes gains.
Comey's testimony, elections in the U.K., London's terror attacks, what a week.
Former FBI Director James Comey gave public testimony to the Senate on President Donald Trump and possible connections with Russia. And markets were riveted.
Valeant is selling its Australian unit iNova to raise $930 million to pay down debt.
Stocks deflate from session highs on Thursday as Wall Street digests public testimony from former FBI Director James Comey.
Wall Street fluctuate as the country held riveted by former FBI director James Comey's public Senate testimony.
Stocks move back into the green on Thursday as former FBI director James Comey delivers public testimony before the Senate Intelligence Committee.
The unit has a strong presence in Australia, South Africa and Asia.
The wait is over. The potentially market-moving Thursday is here.
Citron attacked Mallinckrodt's partnership with Express Scripts ESRX, liking it to the role specialty prescription company Philidor played for embattled pharma company Valeant.
More competition could help overcome the suspicion over drug prices that plagues the would-be business partners' dealings.
A review of data produced by BoardEx reveals that many big and small activist-targeted corporate boards feature young directors in their early-to-mid 30s who work for insurgent fund managers
The embattled activist talked about his troubled investment in Valeant, his efforts at Chipotle and what he'd like to see the Trump Administration focus its energy on.
U.S. stock futures and global shares are higher as investors looked to recoup losses from a week that saw volatility rise amid turmoil in the Trump White House.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer analyzes the day's trending stocks on our daily Facebook Live show, which airs weekdays at 10 a.m. EST.
Here's a technical look at how to play six stocks trending higher with unusual volume flows.
Valeant's reducing debt and extending near-term maturities. It may not be on its last leg, the way most investors thought.
But analysts say Valeant still must bolster lackluster sales in key products and crank out some true earnings drivers from its product pipeline.
The Nasdaq ends at a record for the third session in a row as volatility holds near a two-decade low.
The Nasdaq closes at a record for the third session in a row as volatility holds at its lowest level in more than two decades.
The Nasdaq remain in the green, on track to close at another record, as Apple holds above its newly-secured $800 billion market cap level.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks including Allergan, Valeant Pharmaceuticals, Apple, Tesla, Whole Foods and Cimarex Energy.
Stocks hold slightly higher on Tuesday morning as the low-volatility trading environment remains stable on Wall Street.
Valeant, NantKwest and Aralez were among the biotech movers in premarket trading on Tuesday.
The aerospace components maker lightened up on its own estimates for full year results and now expects 2017 earnings per share of $12.09-$12.33, versus an analyst average $12.22 estimate.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.